Your browser doesn't support javascript.
loading
Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.
Jacobs, Simone; Kröger, Janine; Floegel, Anna; Boeing, Heiner; Drogan, Dagmar; Pischon, Tobias; Fritsche, Andreas; Prehn, Cornelia; Adamski, Jerzy; Isermann, Berend; Weikert, Cornelia; Schulze, Matthias B.
Affiliation
  • Jacobs S; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Kröger J; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Floegel A; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Boeing H; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Drogan D; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Pischon T; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Fritsche A; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Prehn C; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Adamski J; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Isermann B; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Weikert C; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
  • Schulze MB; From the Departments of Molecular Epidemiology (SJ, JK, and MBS) and Epidemiology (A Floegel, HB, CW, and DD), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for
Am J Clin Nutr ; 100(3): 891-900, 2014 Sep.
Article in En | MEDLINE | ID: mdl-25057154
ABSTRACT

BACKGROUND:

The inverse association between coffee consumption and the risk of type 2 diabetes (T2D) is well established; however, little is known about potential mediators of this association.

OBJECTIVE:

We aimed to investigate the association between coffee consumption and diabetes-related biomarkers and their potential role as mediators of the association between coffee consumption and T2D.

DESIGN:

We analyzed a case-cohort study (subcohort n = 1610; verified incident T2D cases n = 417) nested within the European Prospective Investigation into Cancer and Nutrition-Potsdam study involving 27,548 middle-aged participants. Habitual coffee consumption was assessed with a validated, semiquantitative food-frequency questionnaire. We evaluated the association between coffee consumption and several T2D-related biomarkers, such as liver markers (reflected by γ-glutamyltransferase, fetuin-A, and sex hormone-binding globulin), markers of dyslipidemia (high-density lipoprotein cholesterol and triglycerides), inflammation [C-reactive protein (CRP)], an adipokine (adiponectin), and metabolites, stratified by sex.

RESULTS:

Coffee consumption was inversely associated with diacyl-phosphatidylcholine C321 in both sexes and with phenylalanine in men, as well as positively associated with acyl-alkyl-phosphatidylcholines C343, C406, and C425 in women. Furthermore, coffee consumption was inversely associated with fetuin-A (P-trend = 0.06) and CRP in women and γ-glutamyltransferase and triglycerides in men. Coffee consumption tended to be inversely associated with T2D risk in both sexes, reaching significance only in men [HR (95% CI) women ≥4 compared with >0 to <2 cups coffee/d 0.78 (0.46, 1.33); men ≥5 compared with >0 to <2 cups coffee/d 0.40 (0.19, 0.81)]. The association between coffee consumption and T2D risk in men was slightly reduced after adjustment for phenylalanine or lipid markers.

CONCLUSIONS:

Coffee consumption was inversely associated with a diacyl-phosphatidylcholine and liver markers in both sexes and positively associated with certain acyl-alkyl-phosphatidylcholines in women. Furthermore, coffee consumption showed an inverse trend with CRP in women and with triglycerides and phenylalanine in men. However, these markers explained only to a small extent the inverse association between long-term coffee consumption and T2D risk.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Coffee / Diabetes Mellitus, Type 2 / Feeding Behavior Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: Europa Language: En Journal: Am J Clin Nutr Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Coffee / Diabetes Mellitus, Type 2 / Feeding Behavior Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: Europa Language: En Journal: Am J Clin Nutr Year: 2014 Type: Article